The Asia Pacific Clinical Trial Supply & Logistics Market would witness market growth of 8.8% CAGR during the forecast period (2022-2028).
The orchestration of a complete therapeutic supply chain necessitates responsive forecasting and planning. Advanced analytics for patient predictions and interactive response technology (IRT) to assist site and patient forecasting and supply planning are two crucial elements that can contribute to more flexibility. A leading biotechnology company has begun integrating its IRT, RapidResponse, and enterprise resource planning (ERP) systems while also constructing an automated exchange mechanism with logistical service providers.
With enhanced decision and insight generation, this program is bringing increased flexibility, decreased costs, and enhanced investigator and patient experiences. In addition to reducing complaints and deviations, companies that enhance their manufacturing and distribution quality can realize better efficiencies.
The Lighthouse Network is an example of a community of firms that employ digital and analytics technologies along the value chain to improve quality performance while promoting growth, resilience, productivity, and environmental sustainability. Other pharmaceutical companies have already reaped the benefits of digital analytics, including a reduction in quality variations and production costs. Now, the same practices can be used in clinical drug supply operations.
As a 'Pillar Industry,' the Chinese government is emphasizing medication development. AstraZeneca has declared its intention to invest $100 million in China to grow its research operations. The primary aim of the new initiative will be a program to understand better the genetic profile of Chinese patients to create novel medicines for China. India is also one of the most popular Asian nations for R&D endeavors. Easily accessible patient pools, diverse disease profiles in the patient population, an estimated 50 percent cost savings in Phase I studies and 60 percent cost savings in Phase II & III studies, and well-equipped institutions staffed with skilled professionals are the primary forces driving this trend. These developments are driving the expansion of the Asia-Pacific Clinical Trial Supply & Logistics Market.
The China market dominated the Asia Pacific Clinical Trial Supply & Logistics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $407.4 Million by 2028.The Japan market is estimated to grow a CAGR of 8.1% during (2022 - 2028). Additionally, The India market would experience a CAGR of 9.4% during (2022 - 2028).
Based on End-user, the market is segmented into Pharmaceuticals, Biologicals and Medical Device. Based on Therapeutic Area, the market is segmented into Cardiovascular Diseases, Respiratory Diseases, CNS & Mental Disorders, Oncology and Others. Based on Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Service, the market is segmented into Logistics & Distribution, Comparator Sourcing, Storage & Retention, Packaging, Labeling, & Blinding, Manufacturing and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Catalent, Inc., Marken (United Parcel Service of America, Inc.), Piramal Enterprises Limited, FedEx Corporation, Inizio Group Limited (Clayton, Dubilier & Rice), Parexel International Corporation (Phoenix Parentco, Inc.), Almac Group, Movianto (Walden Group SAS), and Deutsche Post DHL Group (The Deutsche Post AG)
The orchestration of a complete therapeutic supply chain necessitates responsive forecasting and planning. Advanced analytics for patient predictions and interactive response technology (IRT) to assist site and patient forecasting and supply planning are two crucial elements that can contribute to more flexibility. A leading biotechnology company has begun integrating its IRT, RapidResponse, and enterprise resource planning (ERP) systems while also constructing an automated exchange mechanism with logistical service providers.
With enhanced decision and insight generation, this program is bringing increased flexibility, decreased costs, and enhanced investigator and patient experiences. In addition to reducing complaints and deviations, companies that enhance their manufacturing and distribution quality can realize better efficiencies.
The Lighthouse Network is an example of a community of firms that employ digital and analytics technologies along the value chain to improve quality performance while promoting growth, resilience, productivity, and environmental sustainability. Other pharmaceutical companies have already reaped the benefits of digital analytics, including a reduction in quality variations and production costs. Now, the same practices can be used in clinical drug supply operations.
As a 'Pillar Industry,' the Chinese government is emphasizing medication development. AstraZeneca has declared its intention to invest $100 million in China to grow its research operations. The primary aim of the new initiative will be a program to understand better the genetic profile of Chinese patients to create novel medicines for China. India is also one of the most popular Asian nations for R&D endeavors. Easily accessible patient pools, diverse disease profiles in the patient population, an estimated 50 percent cost savings in Phase I studies and 60 percent cost savings in Phase II & III studies, and well-equipped institutions staffed with skilled professionals are the primary forces driving this trend. These developments are driving the expansion of the Asia-Pacific Clinical Trial Supply & Logistics Market.
The China market dominated the Asia Pacific Clinical Trial Supply & Logistics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $407.4 Million by 2028.The Japan market is estimated to grow a CAGR of 8.1% during (2022 - 2028). Additionally, The India market would experience a CAGR of 9.4% during (2022 - 2028).
Based on End-user, the market is segmented into Pharmaceuticals, Biologicals and Medical Device. Based on Therapeutic Area, the market is segmented into Cardiovascular Diseases, Respiratory Diseases, CNS & Mental Disorders, Oncology and Others. Based on Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Service, the market is segmented into Logistics & Distribution, Comparator Sourcing, Storage & Retention, Packaging, Labeling, & Blinding, Manufacturing and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Catalent, Inc., Marken (United Parcel Service of America, Inc.), Piramal Enterprises Limited, FedEx Corporation, Inizio Group Limited (Clayton, Dubilier & Rice), Parexel International Corporation (Phoenix Parentco, Inc.), Almac Group, Movianto (Walden Group SAS), and Deutsche Post DHL Group (The Deutsche Post AG)
Scope of the Study
Market Segments Covered in the Report:
By End-user
- Pharmaceuticals
- Biologicals
- Medical Device
By Therapeutic Area
- Cardiovascular Diseases
- Respiratory Diseases
- CNS & Mental Disorders
- Oncology
- Others
By Phase
- Phase III
- Phase II
- Phase I
- Phase IV
By Service
- Logistics & Distribution
- Comparator Sourcing
- Storage & Retention
- Packaging, Labeling, & Blinding
- Manufacturing
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc
- Catalent, Inc
- Marken (United Parcel Service of America, Inc.)
- Piramal Enterprises Limited
- FedEx Corporation
- Inizio Group Limited (Clayton, Dubilier & Rice)
- Parexel International Corporation (Phoenix Parentco, Inc.)
- Almac Group
- Movianto (Walden Group SAS)
- Deutsche Post DHL Group (The Deutsche Post AG)
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Clinical Trial Supply & Logistics Market, by End-user
1.4.2 Asia Pacific Clinical Trial Supply & Logistics Market, by Therapeutic Area
1.4.3 Asia Pacific Clinical Trial Supply & Logistics Market, by Phase
1.4.4 Asia Pacific Clinical Trial Supply & Logistics Market, by Service
1.4.5 Asia Pacific Clinical Trial Supply & Logistics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Scenario and Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Clinical Trial Supply & Logistics Market
Chapter 4. Asia Pacific Clinical Trial Supply & Logistics Market by End-user
4.1 Asia Pacific Pharmaceuticals Market by Country
4.2 Asia Pacific Biologicals Market by Country
4.3 Asia Pacific Medical Device Market by Country
Chapter 5. Asia Pacific Clinical Trial Supply & Logistics Market by Therapeutic Area
5.1 Asia Pacific Cardiovascular Diseases Market by Country
5.2 Asia Pacific Respiratory Diseases Market by Country
5.3 Asia Pacific CNS & Mental Disorders Market by Country
5.4 Asia Pacific Oncology Market by Country
5.5 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Clinical Trial Supply & Logistics Market by Phase
6.1 Asia Pacific Phase III Market by Country
6.2 Asia Pacific Phase II Market by Country
6.3 Asia Pacific Phase I Market by Country
6.4 Asia Pacific Phase IV Market by Country
Chapter 7. Asia Pacific Clinical Trial Supply & Logistics Market by Service
7.1 Asia Pacific Logistics & Distribution Market by Country
7.2 Asia Pacific Comparator Sourcing Market by Country
7.3 Asia Pacific Storage & Retention Market by Country
7.4 Asia Pacific Packaging, Labeling, & Blinding Market by Country
7.5 Asia Pacific Manufacturing Market by Country
7.6 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Clinical Trial Supply & Logistics Market by Country
8.1 China Clinical Trial Supply & Logistics Market
8.1.1 China Clinical Trial Supply & Logistics Market by End-user
8.1.2 China Clinical Trial Supply & Logistics Market by Therapeutic Area
8.1.3 China Clinical Trial Supply & Logistics Market by Phase
8.1.4 China Clinical Trial Supply & Logistics Market by Service
8.2 Japan Clinical Trial Supply & Logistics Market
8.2.1 Japan Clinical Trial Supply & Logistics Market by End-user
8.2.2 Japan Clinical Trial Supply & Logistics Market by Therapeutic Area
8.2.3 Japan Clinical Trial Supply & Logistics Market by Phase
8.2.4 Japan Clinical Trial Supply & Logistics Market by Service
8.3 India Clinical Trial Supply & Logistics Market
8.3.1 India Clinical Trial Supply & Logistics Market by End-user
8.3.2 India Clinical Trial Supply & Logistics Market by Therapeutic Area
8.3.3 India Clinical Trial Supply & Logistics Market by Phase
8.3.4 India Clinical Trial Supply & Logistics Market by Service
8.4 South Korea Clinical Trial Supply & Logistics Market
8.4.1 South Korea Clinical Trial Supply & Logistics Market by End-user
8.4.2 South Korea Clinical Trial Supply & Logistics Market by Therapeutic Area
8.4.3 South Korea Clinical Trial Supply & Logistics Market by Phase
8.4.4 South Korea Clinical Trial Supply & Logistics Market by Service
8.5 Singapore Clinical Trial Supply & Logistics Market
8.5.1 Singapore Clinical Trial Supply & Logistics Market by End-user
8.5.2 Singapore Clinical Trial Supply & Logistics Market by Therapeutic Area
8.5.3 Singapore Clinical Trial Supply & Logistics Market by Phase
8.5.4 Singapore Clinical Trial Supply & Logistics Market by Service
8.6 Malaysia Clinical Trial Supply & Logistics Market
8.6.1 Malaysia Clinical Trial Supply & Logistics Market by End-user
8.6.2 Malaysia Clinical Trial Supply & Logistics Market by Therapeutic Area
8.6.3 Malaysia Clinical Trial Supply & Logistics Market by Phase
8.6.4 Malaysia Clinical Trial Supply & Logistics Market by Service
8.7 Rest of Asia Pacific Clinical Trial Supply & Logistics Market
8.7.1 Rest of Asia Pacific Clinical Trial Supply & Logistics Market by End-user
8.7.2 Rest of Asia Pacific Clinical Trial Supply & Logistics Market by Therapeutic Area
8.7.3 Rest of Asia Pacific Clinical Trial Supply & Logistics Market by Phase
8.7.4 Rest of Asia Pacific Clinical Trial Supply & Logistics Market by Service
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc. (Pantheon)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.5.4 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Catalent, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional & Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.2.5.3 Geographical Expansions:
9.3 Marken (United Parcel Service of America, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.4 Piramal Enterprises Limited
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Recent strategies and developments:
9.4.4.1 Product Launches and Product Expansions:
9.5 Deutsche Post DHL Group (The Deutsche Post AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Acquisition and Mergers:
9.6 FedEx Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.7 Inizio Group Limited (Clayton, Dubilier & Rice)
9.7.1 Company Overview
9.8 Parexel International Corporation (Phoenix Parentco, Inc.)
9.8.1 Company Overview
9.9 Almac Group
9.9.1 Company Overview
9.10. Movianto (Walden Group SAS)
9.10.1 Company Overview
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Catalent, Inc.
- Marken (United Parcel Service of America, Inc.)
- Piramal Enterprises Limited
- FedEx Corporation
- Inizio Group Limited (Clayton, Dubilier & Rice)
- Parexel International Corporation (Phoenix Parentco, Inc.)
- Almac Group
- Movianto (Walden Group SAS)
- Deutsche Post DHL Group (The Deutsche Post AG)
Methodology
LOADING...
